

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.53368837 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.36774606 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.04368137 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.90464826 |
| 5 | vocalization behavior (GO:0071625) | 5.57593163 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.53830347 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.44529074 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.40949711 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.20318396 |
| 10 | neuronal action potential propagation (GO:0019227) | 5.17519105 |
| 11 | glutamate secretion (GO:0014047) | 5.16093281 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.10337985 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.06272483 |
| 14 | regulation of synapse structural plasticity (GO:0051823) | 4.82585284 |
| 15 | protein localization to synapse (GO:0035418) | 4.76362545 |
| 16 | * regulation of neuronal synaptic plasticity (GO:0048168) | 4.71471383 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 4.68731311 |
| 18 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.64268004 |
| 19 | cerebellar granule cell differentiation (GO:0021707) | 4.63934369 |
| 20 | amino acid import (GO:0043090) | 4.63226399 |
| 21 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.56272024 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.55344545 |
| 23 | central nervous system myelination (GO:0022010) | 4.54229242 |
| 24 | axon ensheathment in central nervous system (GO:0032291) | 4.54229242 |
| 25 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.25966169 |
| 26 | neuron cell-cell adhesion (GO:0007158) | 4.21798447 |
| 27 | * exploration behavior (GO:0035640) | 4.19252494 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 4.15546231 |
| 29 | dendritic spine morphogenesis (GO:0060997) | 4.13983067 |
| 30 | layer formation in cerebral cortex (GO:0021819) | 4.12071509 |
| 31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.04079597 |
| 32 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.02711314 |
| 33 | long-term memory (GO:0007616) | 4.01058381 |
| 34 | glutamate receptor signaling pathway (GO:0007215) | 4.00342042 |
| 35 | positive regulation of membrane potential (GO:0045838) | 4.00212096 |
| 36 | potassium ion homeostasis (GO:0055075) | 3.98518112 |
| 37 | cellular potassium ion homeostasis (GO:0030007) | 3.90095510 |
| 38 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.89165571 |
| 39 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.87021073 |
| 40 | gamma-aminobutyric acid transport (GO:0015812) | 3.85954444 |
| 41 | proline transport (GO:0015824) | 3.85543358 |
| 42 | neuron-neuron synaptic transmission (GO:0007270) | 3.84633575 |
| 43 | potassium ion import (GO:0010107) | 3.78615728 |
| 44 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.77350240 |
| 45 | activation of protein kinase A activity (GO:0034199) | 3.77067764 |
| 46 | regulation of synapse maturation (GO:0090128) | 3.71842345 |
| 47 | sodium ion export (GO:0071436) | 3.71722963 |
| 48 | * neuromuscular process controlling balance (GO:0050885) | 3.71598571 |
| 49 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.71427572 |
| 50 | neuromuscular process controlling posture (GO:0050884) | 3.70561137 |
| 51 | regulation of postsynaptic membrane potential (GO:0060078) | 3.64984490 |
| 52 | * regulation of synaptic plasticity (GO:0048167) | 3.64415512 |
| 53 | neurotransmitter transport (GO:0006836) | 3.62512765 |
| 54 | auditory behavior (GO:0031223) | 3.62095088 |
| 55 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.55838456 |
| 56 | prepulse inhibition (GO:0060134) | 3.53381919 |
| 57 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.53274067 |
| 58 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.52369620 |
| 59 | transmission of nerve impulse (GO:0019226) | 3.51538784 |
| 60 | regulation of neurotransmitter secretion (GO:0046928) | 3.49935434 |
| 61 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.48433915 |
| 62 | membrane depolarization during action potential (GO:0086010) | 3.48428204 |
| 63 | positive regulation of synapse maturation (GO:0090129) | 3.47861666 |
| 64 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.43377433 |
| 65 | cellular sodium ion homeostasis (GO:0006883) | 3.42353313 |
| 66 | regulation of neurotransmitter levels (GO:0001505) | 3.41800586 |
| 67 | response to auditory stimulus (GO:0010996) | 3.41641368 |
| 68 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.41234988 |
| 69 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.40673970 |
| 70 | cell migration in hindbrain (GO:0021535) | 3.37129069 |
| 71 | positive regulation of neurotransmitter transport (GO:0051590) | 3.37020521 |
| 72 | glycine transport (GO:0015816) | 3.36430138 |
| 73 | innervation (GO:0060384) | 3.34681763 |
| 74 | acidic amino acid transport (GO:0015800) | 3.34563615 |
| 75 | neurotransmitter uptake (GO:0001504) | 3.33569011 |
| 76 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.32681431 |
| 77 | regulation of vesicle fusion (GO:0031338) | 3.32416051 |
| 78 | negative regulation of dendrite development (GO:2000171) | 3.32021593 |
| 79 | cell communication by electrical coupling (GO:0010644) | 3.31916378 |
| 80 | neuronal ion channel clustering (GO:0045161) | 3.31569371 |
| 81 | presynaptic membrane organization (GO:0097090) | 3.30185772 |
| 82 | membrane depolarization (GO:0051899) | 3.29263745 |
| 83 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.28122733 |
| 84 | regulation of neurotransmitter transport (GO:0051588) | 3.27528023 |
| 85 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.25020562 |
| 86 | postsynaptic membrane organization (GO:0001941) | 3.21294933 |
| 87 | dendritic spine organization (GO:0097061) | 3.21124896 |
| 88 | positive regulation of dendritic spine development (GO:0060999) | 3.21108341 |
| 89 | long-term synaptic potentiation (GO:0060291) | 3.21073314 |
| 90 | synaptic vesicle endocytosis (GO:0048488) | 3.20867525 |
| 91 | chemosensory behavior (GO:0007635) | 3.19919295 |
| 92 | presynaptic membrane assembly (GO:0097105) | 3.19120015 |
| 93 | neuromuscular synaptic transmission (GO:0007274) | 3.18867540 |
| 94 | neuron recognition (GO:0008038) | 3.14869626 |
| 95 | dendrite morphogenesis (GO:0048813) | 3.13757765 |
| 96 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.12364374 |
| 97 | vesicle transport along microtubule (GO:0047496) | 3.11466621 |
| 98 | regulation of ARF protein signal transduction (GO:0032012) | 3.11201417 |
| 99 | positive regulation of dendrite development (GO:1900006) | 3.10282154 |
| 100 | establishment of mitochondrion localization (GO:0051654) | 3.08935876 |
| 101 | membrane hyperpolarization (GO:0060081) | 3.08316553 |
| 102 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.08142995 |
| 103 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.08008939 |
| 104 | regulation of dendritic spine development (GO:0060998) | 3.07784481 |
| 105 | vesicle docking involved in exocytosis (GO:0006904) | 3.07293337 |
| 106 | positive regulation of synaptic transmission (GO:0050806) | 3.07109665 |
| 107 | establishment of synaptic vesicle localization (GO:0097480) | 3.06592715 |
| 108 | synaptic vesicle transport (GO:0048489) | 3.06592715 |
| 109 | * neuromuscular process (GO:0050905) | 3.04276822 |
| 110 | * regulation of synaptic transmission (GO:0050804) | 3.03752888 |
| 111 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.02955071 |
| 112 | * learning (GO:0007612) | 3.02945989 |
| 113 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.00198913 |
| 114 | synaptic transmission (GO:0007268) | 3.00025944 |
| 115 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.98989603 |
| 116 | synapse assembly (GO:0007416) | 2.98950422 |
| 117 | L-amino acid import (GO:0043092) | 2.97118017 |
| 118 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.95919937 |
| 119 | behavioral defense response (GO:0002209) | 2.94037588 |
| 120 | behavioral fear response (GO:0001662) | 2.94037588 |
| 121 | intraspecies interaction between organisms (GO:0051703) | 2.93388562 |
| 122 | social behavior (GO:0035176) | 2.93388562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.25301203 |
| 2 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.27955453 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.25986483 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.12771580 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.04233581 |
| 6 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.02717322 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.99402939 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.92647311 |
| 9 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.87904141 |
| 10 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.87904141 |
| 11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.70744027 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.69427870 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.68007230 |
| 14 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.62795492 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.57290387 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.56519075 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.56423897 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.47633741 |
| 19 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.47499574 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.47134601 |
| 21 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.41864773 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.39531304 |
| 23 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.33635356 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.33019692 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.23219643 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.21974353 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.95177580 |
| 28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.78436527 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.66157636 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.64680479 |
| 31 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.52848582 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.51104206 |
| 33 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.51058563 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43453530 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42726386 |
| 36 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.42088090 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.41927180 |
| 38 | KDM2B_26808549_Chip-Seq_K562_Human | 1.40499670 |
| 39 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.33468811 |
| 40 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33030728 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32997517 |
| 42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.32222324 |
| 43 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31425920 |
| 44 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.30959304 |
| 45 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.27551538 |
| 46 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.26139900 |
| 47 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.25961670 |
| 48 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.23788086 |
| 49 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.22135897 |
| 50 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.21663995 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.21572781 |
| 52 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19482299 |
| 53 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18397988 |
| 54 | AR_19668381_ChIP-Seq_PC3_Human | 1.18016432 |
| 55 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17818412 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17696434 |
| 57 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17543916 |
| 58 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.17455977 |
| 59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16171207 |
| 60 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.15270123 |
| 61 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14102143 |
| 62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12938854 |
| 63 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.12932485 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09362946 |
| 65 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.07700333 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06534727 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.05993719 |
| 68 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05966582 |
| 69 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.05799394 |
| 70 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05743378 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05148897 |
| 72 | P300_19829295_ChIP-Seq_ESCs_Human | 1.05135420 |
| 73 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05092699 |
| 74 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04346701 |
| 75 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.03538752 |
| 76 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02778804 |
| 77 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00852109 |
| 78 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.00319938 |
| 79 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.97327925 |
| 80 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.96839858 |
| 81 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96499251 |
| 82 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96326407 |
| 83 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.96234189 |
| 84 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.96070356 |
| 85 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.95853770 |
| 86 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.95846435 |
| 87 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.95097039 |
| 88 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94566217 |
| 89 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94078715 |
| 90 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94040742 |
| 91 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.93232122 |
| 92 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92228290 |
| 93 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91616451 |
| 94 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91399398 |
| 95 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90898175 |
| 96 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.90304503 |
| 97 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.90110066 |
| 98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88410905 |
| 99 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88280457 |
| 100 | TCF4_23295773_ChIP-Seq_U87_Human | 0.88132617 |
| 101 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86612206 |
| 102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86278931 |
| 103 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86202541 |
| 104 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86018667 |
| 105 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85913837 |
| 106 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85544166 |
| 107 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.84178419 |
| 108 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.83736328 |
| 109 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.83157883 |
| 110 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82523711 |
| 111 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.81204643 |
| 112 | * P68_20966046_ChIP-Seq_HELA_Human | 0.81003759 |
| 113 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80308452 |
| 114 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.80084082 |
| 115 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.79784079 |
| 116 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.79207745 |
| 117 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78841277 |
| 118 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.78826016 |
| 119 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.78420191 |
| 120 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77790948 |
| 121 | RXR_22108803_ChIP-Seq_LS180_Human | 0.75607114 |
| 122 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.75144489 |
| 123 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.74948598 |
| 124 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.74863925 |
| 125 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.73744352 |
| 126 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.70741868 |
| 127 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.69710099 |
| 128 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.69710099 |
| 129 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.69626614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.97807543 |
| 2 | MP0003880_abnormal_central_pattern | 4.65641992 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.24629672 |
| 4 | MP0004270_analgesia | 4.23792163 |
| 5 | MP0009745_abnormal_behavioral_response | 3.47338629 |
| 6 | MP0002822_catalepsy | 3.37105217 |
| 7 | * MP0002063_abnormal_learning/memory/cond | 3.33784975 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.20319931 |
| 9 | MP0009046_muscle_twitch | 3.18094382 |
| 10 | MP0002064_seizures | 3.14358784 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.95848195 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.84309827 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.72808822 |
| 14 | * MP0002572_abnormal_emotion/affect_behav | 2.69296718 |
| 15 | * MP0002272_abnormal_nervous_system | 2.65333031 |
| 16 | MP0001486_abnormal_startle_reflex | 2.61134387 |
| 17 | MP0002736_abnormal_nociception_after | 2.49167564 |
| 18 | MP0002733_abnormal_thermal_nociception | 2.29901027 |
| 19 | MP0004858_abnormal_nervous_system | 2.26313591 |
| 20 | MP0001970_abnormal_pain_threshold | 2.22093370 |
| 21 | MP0001501_abnormal_sleep_pattern | 2.17442734 |
| 22 | MP0006276_abnormal_autonomic_nervous | 1.99096114 |
| 23 | MP0003329_amyloid_beta_deposits | 1.98150723 |
| 24 | MP0002909_abnormal_adrenal_gland | 1.95330892 |
| 25 | MP0004811_abnormal_neuron_physiology | 1.93922739 |
| 26 | MP0002184_abnormal_innervation | 1.93003134 |
| 27 | * MP0002067_abnormal_sensory_capabilities | 1.91682712 |
| 28 | * MP0008569_lethality_at_weaning | 1.91557324 |
| 29 | MP0001440_abnormal_grooming_behavior | 1.90096553 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.79007906 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.76073008 |
| 32 | MP0004924_abnormal_behavior | 1.68729957 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.68729957 |
| 34 | MP0003879_abnormal_hair_cell | 1.67806705 |
| 35 | MP0000955_abnormal_spinal_cord | 1.67560513 |
| 36 | MP0003123_paternal_imprinting | 1.62982800 |
| 37 | MP0000778_abnormal_nervous_system | 1.53436126 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.53336736 |
| 39 | MP0001984_abnormal_olfaction | 1.48098228 |
| 40 | MP0002882_abnormal_neuron_morphology | 1.43453229 |
| 41 | * MP0002066_abnormal_motor_capabilities/c | 1.40909629 |
| 42 | MP0003633_abnormal_nervous_system | 1.38810677 |
| 43 | MP0004885_abnormal_endolymph | 1.32085080 |
| 44 | MP0001529_abnormal_vocalization | 1.29852704 |
| 45 | MP0004142_abnormal_muscle_tone | 1.28365731 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.19771176 |
| 47 | MP0001905_abnormal_dopamine_level | 1.18519769 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.17603846 |
| 49 | MP0003631_nervous_system_phenotype | 1.15256944 |
| 50 | MP0001188_hyperpigmentation | 1.13991991 |
| 51 | MP0003787_abnormal_imprinting | 1.10614904 |
| 52 | MP0003075_altered_response_to | 1.09433464 |
| 53 | MP0004145_abnormal_muscle_electrophysio | 1.04643182 |
| 54 | MP0002152_abnormal_brain_morphology | 1.03227460 |
| 55 | MP0001346_abnormal_lacrimal_gland | 1.03106836 |
| 56 | MP0008872_abnormal_physiological_respon | 1.02898149 |
| 57 | MP0008877_abnormal_DNA_methylation | 1.01052559 |
| 58 | MP0002229_neurodegeneration | 1.00879821 |
| 59 | MP0003283_abnormal_digestive_organ | 1.00602509 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.00257464 |
| 61 | MP0008874_decreased_physiological_sensi | 0.99664904 |
| 62 | MP0005409_darkened_coat_color | 0.93727993 |
| 63 | MP0010386_abnormal_urinary_bladder | 0.93110355 |
| 64 | MP0000751_myopathy | 0.92715352 |
| 65 | MP0005535_abnormal_body_temperature | 0.90756566 |
| 66 | MP0003122_maternal_imprinting | 0.89283569 |
| 67 | MP0000604_amyloidosis | 0.88174748 |
| 68 | * MP0002069_abnormal_eating/drinking_beha | 0.87502154 |
| 69 | MP0001177_atelectasis | 0.86001099 |
| 70 | MP0003634_abnormal_glial_cell | 0.81918477 |
| 71 | MP0000920_abnormal_myelination | 0.81382552 |
| 72 | MP0008961_abnormal_basal_metabolism | 0.80620162 |
| 73 | MP0004085_abnormal_heartbeat | 0.80075165 |
| 74 | MP0001963_abnormal_hearing_physiology | 0.77574975 |
| 75 | MP0003632_abnormal_nervous_system | 0.77259564 |
| 76 | MP0004742_abnormal_vestibular_system | 0.77023209 |
| 77 | MP0005623_abnormal_meninges_morphology | 0.76782477 |
| 78 | MP0000013_abnormal_adipose_tissue | 0.75879669 |
| 79 | MP0005167_abnormal_blood-brain_barrier | 0.75387656 |
| 80 | MP0003121_genomic_imprinting | 0.74621905 |
| 81 | MP0002752_abnormal_somatic_nervous | 0.74482392 |
| 82 | MP0003690_abnormal_glial_cell | 0.72368254 |
| 83 | MP0000579_abnormal_nail_morphology | 0.72197227 |
| 84 | MP0001348_abnormal_lacrimal_gland | 0.70176833 |
| 85 | MP0005394_taste/olfaction_phenotype | 0.68333170 |
| 86 | MP0005499_abnormal_olfactory_system | 0.68333170 |
| 87 | MP0001986_abnormal_taste_sensitivity | 0.64556954 |
| 88 | MP0001485_abnormal_pinna_reflex | 0.63816233 |
| 89 | MP0000631_abnormal_neuroendocrine_gland | 0.62084077 |
| 90 | MP0002638_abnormal_pupillary_reflex | 0.61311552 |
| 91 | MP0001664_abnormal_digestion | 0.60441936 |
| 92 | MP0005551_abnormal_eye_electrophysiolog | 0.60177268 |
| 93 | MP0002653_abnormal_ependyma_morphology | 0.60140654 |
| 94 | MP0000566_synostosis | 0.60091256 |
| 95 | MP0000026_abnormal_inner_ear | 0.60090383 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.58557857 |
| 97 | MP0003172_abnormal_lysosome_physiology | 0.58502854 |
| 98 | MP0003938_abnormal_ear_development | 0.58445415 |
| 99 | MP0002751_abnormal_autonomic_nervous | 0.58383035 |
| 100 | MP0004510_myositis | 0.57402808 |
| 101 | MP0002090_abnormal_vision | 0.56263409 |
| 102 | MP0004130_abnormal_muscle_cell | 0.53860843 |
| 103 | MP0002249_abnormal_larynx_morphology | 0.53801111 |
| 104 | MP0004147_increased_porphyrin_level | 0.52198690 |
| 105 | MP0001299_abnormal_eye_distance/ | 0.52047417 |
| 106 | MP0001943_abnormal_respiration | 0.51260049 |
| 107 | * MP0010769_abnormal_survival | 0.50094485 |
| 108 | * MP0003956_abnormal_body_size | 0.49728653 |
| 109 | MP0005166_decreased_susceptibility_to | 0.47831933 |
| 110 | MP0002873_normal_phenotype | 0.47762394 |
| 111 | MP0010770_preweaning_lethality | 0.47516426 |
| 112 | MP0002082_postnatal_lethality | 0.47516426 |
| 113 | MP0003861_abnormal_nervous_system | 0.47237865 |
| 114 | * MP0010768_mortality/aging | 0.46868937 |
| 115 | MP0004484_altered_response_of | 0.46844970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 8.72395771 |
| 2 | Focal motor seizures (HP:0011153) | 7.76723800 |
| 3 | Focal seizures (HP:0007359) | 5.88582324 |
| 4 | Visual hallucinations (HP:0002367) | 5.59803647 |
| 5 | Febrile seizures (HP:0002373) | 4.72502669 |
| 6 | Atonic seizures (HP:0010819) | 4.64190054 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.53328284 |
| 8 | Epileptic encephalopathy (HP:0200134) | 4.44868453 |
| 9 | Absence seizures (HP:0002121) | 4.05249124 |
| 10 | Ankle clonus (HP:0011448) | 4.04770156 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 4.00215253 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.83487151 |
| 13 | Dialeptic seizures (HP:0011146) | 3.71113105 |
| 14 | Gaze-evoked nystagmus (HP:0000640) | 3.58499764 |
| 15 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.49292889 |
| 16 | Poor eye contact (HP:0000817) | 3.44477408 |
| 17 | * Action tremor (HP:0002345) | 3.43633401 |
| 18 | Cerebral hypomyelination (HP:0006808) | 3.42481356 |
| 19 | Tetraplegia (HP:0002445) | 3.42115597 |
| 20 | Dysdiadochokinesis (HP:0002075) | 3.32267794 |
| 21 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.31634248 |
| 22 | * Depression (HP:0000716) | 3.28292860 |
| 23 | Broad-based gait (HP:0002136) | 3.25858501 |
| 24 | Truncal ataxia (HP:0002078) | 3.25716797 |
| 25 | Postural instability (HP:0002172) | 3.24068782 |
| 26 | Mutism (HP:0002300) | 3.23013378 |
| 27 | Dysmetria (HP:0001310) | 3.15932034 |
| 28 | Annular pancreas (HP:0001734) | 3.13826009 |
| 29 | Abnormal social behavior (HP:0012433) | 3.13820433 |
| 30 | Impaired social interactions (HP:0000735) | 3.13820433 |
| 31 | Papilledema (HP:0001085) | 3.13047810 |
| 32 | Abnormality of the lower motor neuron (HP:0002366) | 3.08034603 |
| 33 | Torticollis (HP:0000473) | 3.06549398 |
| 34 | Abnormal eating behavior (HP:0100738) | 3.05080716 |
| 35 | * Anxiety (HP:0000739) | 3.02821754 |
| 36 | Scanning speech (HP:0002168) | 3.00846266 |
| 37 | Ventricular fibrillation (HP:0001663) | 2.98181730 |
| 38 | Impaired smooth pursuit (HP:0007772) | 2.96836513 |
| 39 | Urinary urgency (HP:0000012) | 2.96050003 |
| 40 | Amblyopia (HP:0000646) | 2.93957562 |
| 41 | Spastic gait (HP:0002064) | 2.91575977 |
| 42 | Focal dystonia (HP:0004373) | 2.90501801 |
| 43 | Akinesia (HP:0002304) | 2.88982229 |
| 44 | Genetic anticipation (HP:0003743) | 2.77336421 |
| 45 | Hemiplegia (HP:0002301) | 2.75636117 |
| 46 | Sleep apnea (HP:0010535) | 2.74345111 |
| 47 | Intention tremor (HP:0002080) | 2.69350675 |
| 48 | Hemiparesis (HP:0001269) | 2.69327406 |
| 49 | Stereotypic behavior (HP:0000733) | 2.68313242 |
| 50 | Progressive inability to walk (HP:0002505) | 2.64235238 |
| 51 | Craniofacial dystonia (HP:0012179) | 2.63529171 |
| 52 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.53585951 |
| 53 | Megalencephaly (HP:0001355) | 2.49258218 |
| 54 | Spastic tetraparesis (HP:0001285) | 2.45151057 |
| 55 | Pointed chin (HP:0000307) | 2.43959410 |
| 56 | Dysmetric saccades (HP:0000641) | 2.40699584 |
| 57 | Impaired vibratory sensation (HP:0002495) | 2.39502855 |
| 58 | Fetal akinesia sequence (HP:0001989) | 2.39485756 |
| 59 | * Bradykinesia (HP:0002067) | 2.35668158 |
| 60 | Limb dystonia (HP:0002451) | 2.33437802 |
| 61 | Insomnia (HP:0100785) | 2.33415702 |
| 62 | Pheochromocytoma (HP:0002666) | 2.30589430 |
| 63 | Bundle branch block (HP:0011710) | 2.28462203 |
| 64 | Diplopia (HP:0000651) | 2.25477631 |
| 65 | Abnormality of binocular vision (HP:0011514) | 2.25477631 |
| 66 | Choreoathetosis (HP:0001266) | 2.22895539 |
| 67 | Lower limb muscle weakness (HP:0007340) | 2.22381172 |
| 68 | Split foot (HP:0001839) | 2.18418778 |
| 69 | CNS hypomyelination (HP:0003429) | 2.17206208 |
| 70 | Insidious onset (HP:0003587) | 2.17024784 |
| 71 | Termporal pattern (HP:0011008) | 2.17024784 |
| 72 | Clonus (HP:0002169) | 2.16251258 |
| 73 | Epileptiform EEG discharges (HP:0011182) | 2.15743205 |
| 74 | Neurofibrillary tangles (HP:0002185) | 2.15648555 |
| 75 | Status epilepticus (HP:0002133) | 2.15387815 |
| 76 | Hyperventilation (HP:0002883) | 2.13573205 |
| 77 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.13218867 |
| 78 | Lower limb asymmetry (HP:0100559) | 2.12955541 |
| 79 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.12741115 |
| 80 | Abnormal EKG (HP:0003115) | 2.11901398 |
| 81 | EEG with generalized epileptiform discharges (HP:0011198) | 2.11072890 |
| 82 | Agitation (HP:0000713) | 2.10884151 |
| 83 | Abnormality of pain sensation (HP:0010832) | 2.09661136 |
| 84 | Impaired pain sensation (HP:0007328) | 2.09661136 |
| 85 | Drooling (HP:0002307) | 2.07646359 |
| 86 | Excessive salivation (HP:0003781) | 2.07646359 |
| 87 | Incomplete penetrance (HP:0003829) | 2.04439427 |
| 88 | Resting tremor (HP:0002322) | 2.03665875 |
| 89 | Hypsarrhythmia (HP:0002521) | 2.03334654 |
| 90 | Peripheral hypomyelination (HP:0007182) | 2.00160182 |
| 91 | Spinal canal stenosis (HP:0003416) | 1.99264636 |
| 92 | Cerebral inclusion bodies (HP:0100314) | 1.99095226 |
| 93 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.98922359 |
| 94 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.98922359 |
| 95 | Neuroendocrine neoplasm (HP:0100634) | 1.97749268 |
| 96 | Abnormality of the corticospinal tract (HP:0002492) | 1.97563809 |
| 97 | Obstructive sleep apnea (HP:0002870) | 1.97516353 |
| 98 | Abnormality of saccadic eye movements (HP:0000570) | 1.97170154 |
| 99 | Failure to thrive in infancy (HP:0001531) | 1.96545675 |
| 100 | Rapidly progressive (HP:0003678) | 1.95801369 |
| 101 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.93158788 |
| 102 | Aplasia of the phalanges of the hand (HP:0009802) | 1.93158788 |
| 103 | Aplasia involving bones of the extremities (HP:0009825) | 1.93158788 |
| 104 | Gait ataxia (HP:0002066) | 1.92051912 |
| 105 | Increased circulating renin level (HP:0000848) | 1.91536880 |
| 106 | Absent speech (HP:0001344) | 1.90161467 |
| 107 | * Delusions (HP:0000746) | 1.89047149 |
| 108 | * Rigidity (HP:0002063) | 1.88882004 |
| 109 | Inability to walk (HP:0002540) | 1.86741095 |
| 110 | Generalized myoclonic seizures (HP:0002123) | 1.86492984 |
| 111 | Turricephaly (HP:0000262) | 1.86353595 |
| 112 | Hypercortisolism (HP:0001578) | 1.85348707 |
| 113 | Neuronal loss in central nervous system (HP:0002529) | 1.84816186 |
| 114 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.84654605 |
| 115 | Bronchomalacia (HP:0002780) | 1.84561160 |
| 116 | Anosmia (HP:0000458) | 1.84259241 |
| 117 | Lower limb amyotrophy (HP:0007210) | 1.82798567 |
| 118 | Polyphagia (HP:0002591) | 1.80289566 |
| 119 | Amyotrophic lateral sclerosis (HP:0007354) | 1.80152349 |
| 120 | Psychosis (HP:0000709) | 1.79930493 |
| 121 | Spastic tetraplegia (HP:0002510) | 1.66235261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.68112505 |
| 2 | EPHA4 | 4.51220451 |
| 3 | MAP3K9 | 3.99323562 |
| 4 | MINK1 | 3.06550265 |
| 5 | NTRK1 | 2.65450109 |
| 6 | MARK1 | 2.59754636 |
| 7 | MAP3K4 | 2.59666794 |
| 8 | DAPK2 | 2.58119631 |
| 9 | KSR2 | 2.51789060 |
| 10 | PRKD3 | 2.43745058 |
| 11 | MAP2K7 | 2.32662358 |
| 12 | PAK6 | 2.28800409 |
| 13 | CAMKK1 | 2.28737378 |
| 14 | RIPK4 | 1.96866271 |
| 15 | NTRK2 | 1.92669764 |
| 16 | MAP3K12 | 1.87887492 |
| 17 | MAP2K4 | 1.73290898 |
| 18 | TNIK | 1.64471790 |
| 19 | ARAF | 1.62819265 |
| 20 | CDK5 | 1.61493389 |
| 21 | KSR1 | 1.53642847 |
| 22 | DAPK1 | 1.52317856 |
| 23 | STK38 | 1.44999242 |
| 24 | FES | 1.38339913 |
| 25 | CAMKK2 | 1.37981143 |
| 26 | MAPK13 | 1.37913518 |
| 27 | CDK19 | 1.36694641 |
| 28 | MAP3K2 | 1.36262302 |
| 29 | PRPF4B | 1.35157757 |
| 30 | MAP3K13 | 1.28465762 |
| 31 | GRK5 | 1.27735521 |
| 32 | UHMK1 | 1.26721366 |
| 33 | CASK | 1.23138161 |
| 34 | PRKCG | 1.20528757 |
| 35 | SIK2 | 1.19002588 |
| 36 | PINK1 | 1.18906174 |
| 37 | LMTK2 | 1.16791846 |
| 38 | TAOK1 | 1.10006993 |
| 39 | CAMK1 | 1.08551382 |
| 40 | TYRO3 | 1.06816467 |
| 41 | PHKG2 | 1.04740484 |
| 42 | PHKG1 | 1.04740484 |
| 43 | PLK2 | 0.96150624 |
| 44 | MUSK | 0.96150056 |
| 45 | SGK494 | 0.95124263 |
| 46 | SGK223 | 0.95124263 |
| 47 | RET | 0.94961580 |
| 48 | PRKCH | 0.93154342 |
| 49 | RAF1 | 0.93095998 |
| 50 | TNK2 | 0.90774819 |
| 51 | PKN1 | 0.89682474 |
| 52 | STK11 | 0.86360532 |
| 53 | CDK18 | 0.85604330 |
| 54 | LATS2 | 0.84461621 |
| 55 | CDK15 | 0.84435176 |
| 56 | SGK2 | 0.82929715 |
| 57 | CDK14 | 0.82475613 |
| 58 | CAMK2A | 0.81826245 |
| 59 | MAP3K1 | 0.79670659 |
| 60 | MAPK12 | 0.78025133 |
| 61 | ALK | 0.77221784 |
| 62 | PDK1 | 0.75735557 |
| 63 | CDK11A | 0.74668083 |
| 64 | SCYL2 | 0.74337526 |
| 65 | SGK3 | 0.74256049 |
| 66 | PTK2B | 0.72666256 |
| 67 | MARK2 | 0.72272133 |
| 68 | PDPK1 | 0.68795198 |
| 69 | PNCK | 0.64411249 |
| 70 | CAMK2B | 0.62976013 |
| 71 | MAP3K11 | 0.62073186 |
| 72 | BMPR2 | 0.61740304 |
| 73 | BRSK1 | 0.60796394 |
| 74 | PAK3 | 0.56942024 |
| 75 | SGK1 | 0.56817698 |
| 76 | MATK | 0.56557073 |
| 77 | RIPK1 | 0.56281626 |
| 78 | LIMK1 | 0.56007440 |
| 79 | CAMK4 | 0.53164591 |
| 80 | DYRK1A | 0.52686322 |
| 81 | CAMK1G | 0.51728109 |
| 82 | NEK1 | 0.51162979 |
| 83 | DYRK2 | 0.51112428 |
| 84 | CSNK1G2 | 0.50908692 |
| 85 | MAP2K1 | 0.50626640 |
| 86 | CAMK1D | 0.48998032 |
| 87 | WNK1 | 0.48885515 |
| 88 | FGFR2 | 0.48339534 |
| 89 | MAP3K7 | 0.48093967 |
| 90 | PRKCZ | 0.45786003 |
| 91 | * RPS6KA3 | 0.44735883 |
| 92 | NEK6 | 0.43124229 |
| 93 | MAPK10 | 0.42013412 |
| 94 | CAMK2G | 0.41818270 |
| 95 | FYN | 0.41468617 |
| 96 | RPS6KA2 | 0.41353590 |
| 97 | OXSR1 | 0.38927950 |
| 98 | FER | 0.37783382 |
| 99 | CDC42BPA | 0.37320400 |
| 100 | ROCK2 | 0.36257516 |
| 101 | DAPK3 | 0.35873813 |
| 102 | PRKCE | 0.35462495 |
| 103 | CSNK1E | 0.34046368 |
| 104 | CAMK2D | 0.33280425 |
| 105 | PRKG2 | 0.32419352 |
| 106 | PRKD2 | 0.29316993 |
| 107 | TAOK2 | 0.29257956 |
| 108 | BRAF | 0.28872030 |
| 109 | CSNK1D | 0.27791253 |
| 110 | TESK1 | 0.27102774 |
| 111 | GSK3B | 0.27101522 |
| 112 | PRKCB | 0.25838636 |
| 113 | MAP2K6 | 0.25787800 |
| 114 | PRKCA | 0.25523177 |
| 115 | MAPK8 | 0.24532218 |
| 116 | ROCK1 | 0.24432429 |
| 117 | DMPK | 0.23948708 |
| 118 | CCNB1 | 0.23606585 |
| 119 | RPS6KB1 | 0.23119786 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.34410930 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.29165807 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 3.12238256 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.72832656 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.71451489 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.56275167 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.54102663 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.47776698 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.47619438 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.45570493 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.39259434 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.22223983 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.17492373 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.12271501 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.07339753 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 2.00332156 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.96797048 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.95218043 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.76879864 |
| 20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.69524775 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.68198738 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.67663592 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.66719567 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.62894977 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.61325922 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.59636237 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.57979386 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.52900298 |
| 29 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.48334738 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.41818978 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.41289517 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28240322 |
| 33 | Glioma_Homo sapiens_hsa05214 | 1.25222141 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.23375399 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.21557260 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.17571426 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14065989 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.12886319 |
| 39 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.09430838 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08202684 |
| 41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.06115273 |
| 42 | Melanogenesis_Homo sapiens_hsa04916 | 1.05253966 |
| 43 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.04105198 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99623372 |
| 45 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.97625064 |
| 46 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95718815 |
| 47 | Axon guidance_Homo sapiens_hsa04360 | 0.95448368 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93208652 |
| 49 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.91726037 |
| 50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90622906 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89327619 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87028521 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.86389988 |
| 54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.83683813 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83403595 |
| 56 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80315220 |
| 57 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.79138507 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77557090 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75740743 |
| 60 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73871713 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72859765 |
| 62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69647622 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69223227 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63138579 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.62393473 |
| 66 | Phototransduction_Homo sapiens_hsa04744 | 0.61368720 |
| 67 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60551690 |
| 68 | Alcoholism_Homo sapiens_hsa05034 | 0.58835378 |
| 69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58739803 |
| 70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58265187 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57787680 |
| 72 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56933033 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56557840 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54488531 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54117691 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53811823 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53382943 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53043642 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51919727 |
| 80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.50935667 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48696511 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.47728462 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.45987653 |
| 84 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.44157874 |
| 85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44149702 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44065976 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42844242 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42579888 |
| 89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41803670 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40685835 |
| 91 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40620563 |
| 92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.39911226 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37700331 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37616446 |
| 95 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.37041177 |
| 96 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.36968395 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35154103 |
| 98 | Alzheimers disease_Homo sapiens_hsa05010 | 0.34258438 |
| 99 | Tight junction_Homo sapiens_hsa04530 | 0.33819766 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33736290 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33547706 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.33197932 |
| 103 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.32714918 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31718003 |
| 105 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30843552 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30705448 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30538733 |
| 108 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.28774564 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.27239395 |
| 110 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.24834029 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.22736394 |
| 112 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.20981140 |
| 113 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.18211416 |

